- Home
- NSTS vs VRCA Comparison
NSTS vs VRCA Comparison
Compare NSTS & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSTS
- VRCA
- Stock Information
- Founded
- NSTS 1921
- VRCA 2013
- Country
- NSTS United States
- VRCA United States
- Employees
- NSTS N/A
- VRCA N/A
- Industry
- NSTS Savings Institutions
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- NSTS Finance
- VRCA Health Care
- Exchange
- NSTS Nasdaq
- VRCA Nasdaq
- Market Cap
- NSTS 63.0M
- VRCA 58.7M
- IPO Year
- NSTS N/A
- VRCA 2018
- Fundamental
- Price
- NSTS $11.54
- VRCA $4.41
- Analyst Decision
- NSTS
- VRCA Hold
- Analyst Count
- NSTS 0
- VRCA 5
- Target Price
- NSTS N/A
- VRCA $60.00
- AVG Volume (30 Days)
- NSTS 1.6K
- VRCA 39.3K
- Earning Date
- NSTS 11-12-2025
- VRCA 11-03-2025
- Dividend Yield
- NSTS N/A
- VRCA N/A
- EPS Growth
- NSTS N/A
- VRCA N/A
- EPS
- NSTS N/A
- VRCA N/A
- Revenue
- NSTS $9,435,000.00
- VRCA $14,704,000.00
- Revenue This Year
- NSTS N/A
- VRCA $332.45
- Revenue Next Year
- NSTS N/A
- VRCA $12.85
- P/E Ratio
- NSTS N/A
- VRCA N/A
- Revenue Growth
- NSTS 69.39
- VRCA 5.72
- 52 Week Low
- NSTS $9.50
- VRCA $3.82
- 52 Week High
- NSTS $13.32
- VRCA $20.13
- Technical
- Relative Strength Index (RSI)
- NSTS 31.07
- VRCA 29.87
- Support Level
- NSTS $11.80
- VRCA $4.87
- Resistance Level
- NSTS $12.00
- VRCA $5.23
- Average True Range (ATR)
- NSTS 0.09
- VRCA 0.35
- MACD
- NSTS -0.02
- VRCA -0.05
- Stochastic Oscillator
- NSTS 11.68
- VRCA 3.41
About NSTS NSTS Bancorp Inc.
NSTS Bancorp Inc is a savings and loan holding company regulated Federal Reserve Board. The company was formed to serve as the North Shore Trust and Savings stock holding company. The Bank is a wholly-owned subsidiary of the company and operates as a traditional savings institution focused on serving the banking needs of customers in market area of Lake County, Illinois and adjacent communities.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.